New information has become available to help guide clinicians on the thorny issue of whether to give oral anticoagulation to patients with AF who have had an intracranial hemorrhage.
Metabolic dysfunction–associated steatotic liver disease (MASLD) was associated with increased risks for hepatic and extrahepatic complications in a large meta-analysis.
In a meta-analysis, researchers concluded that surgery does not improve survival and "should not be routinely offered to patients with metastatic disease."